Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Laura Arletti"'
Autor:
Paolo Pavone, Laura Arletti, Fiorella Ilariucci, Tommaso Albano, Deborah Lusetti, Romina Corsini, Francesco Merli, Sergio Mezzadri
Publikováno v:
Journal of Fungi, Vol 10, Iss 8, p 584 (2024)
Treatment with CCR-4 antagonists has been shown to be protective against the development of invasive pulmonary aspergillosis in animal models. Herein, we present a case of fatal invasive pulmonary aspergillosis in a patient receiving Mogamulizumab. A
Externí odkaz:
https://doaj.org/article/c742af0275e34ffa9653d7b8cc4007d9
Autor:
Teresa Calimeri, Sara Steffanoni, Alice Laurenge, Christopher P. Fox, Carole Soussain, Christian Grommes, Maria Chiara Tisi, Jesca Boot, Nicola Crosbie, Carlo Visco, Luca Arcaini, Sridhar Chaganti, Alvaro J. Alencar, Daniele Armiento, Ilaria Romano, Marianna C. Sassone, Jorg Dietrich, Gilad Itchaki, Riccardo Bruna, Nicola S Fracchiolla, Laura Arletti, Adriano Venditti, Stephen Booth, Pellegrino Musto, Khe Hoang-Xuan, Tracy Batchelor, Kate Cwynarski, Andrés J.M. Ferreri
Publikováno v:
Blood. 140:3785-3787
Autor:
Sara Steffanoni, Teresa Calimeri, Alice Laurenge, Christopher P. Fox, Carole Soussain, Christian Grommes, Maria Chiara Tisi, Jesca Boot, Nicola Crosbie, Carlo Visco, Luca Arcaini, Sridhar Chaganti, Marianna C. Sassone, Alvaro Alencar, Daniele Armiento, Ilaria Romano, Jorg Dietrich, Gilad Itchaki, Riccardo Bruna, Nicola S. Fracchiolla, Laura Arletti, Adriano Venditti, Stephen Booth, Pellegrino Musto, Khê Hoang Xuan, Tracy T. Batchelor, Kate Cwynarski, Andrés J. M. Ferreri
Publikováno v:
British journal of haematologyREFERENCES. 199(4)
To optimise management of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection identifying high-risk patients and maintaining treatment dose intensity is an important issue in patients with aggressive lymphomas. In the present study
Direct oral anticoagulants for atrial fibrillation in patients with congenital factor VII deficiency
The management of anticoagulant therapy (OAT) in patients with factor VII (FVII) deficiency is a very challenging clinical issue, as warfarin further reduces FVII levels, thus potentially increasing bleeding risk. On the other hand, the International
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dd588108be517db2da995a2127af00b
https://hdl.handle.net/11380/1222773
https://hdl.handle.net/11380/1222773
Autor:
Stefania Fiorcari, Monica Maccaferri, Stefania Benatti, Roberto Marasca, Rossana Maffei, Leonardo Potenza, Laura Arletti, Mario Luppi
Publikováno v:
Blood Reviews. 40:100635
The Bruton tyrosine kinase (BTK) inhibitor ibrutinib is increasingly used in the treatment of chronic lymphocytic leukemia (CLL). Moreover, very promising results have been reported in other B-cell malignancies, including primary central nervous syst
Autor:
Vincenzo Nasillo, Elisabetta Lugli, Valeria Pioli, Laura Arletti, Paola Bresciani, Monica Maccaferri, Valeria Coluccio, Elisabetta Colaci, Mario Luppi, Andrea Messerotti, G. Ceccherelli, Maria Teresa Mariano, Angela Cuoghi, Ambra Paolini, Ivana Lagreca, Franco Narni, Chiara Quadrelli, Valeria Fantuzzi, Daniele Campioli, Giovanni Riva, Andrea Gilioli, Patrizia Barozzi, Leonardo Potenza, Roberto Marasca, Patrizia Comoli, Fabio Forghieri, Patrizia Zucchini, Tommaso Trenti, Daniela Vallerini, Monica Morselli
Publikováno v:
Leukemialymphoma. 59(1)
Biosimilars of filgrastim have shown to be comparable to the originator (Neupogen®, Amgen Inc., CA) in terms of pharmacodynamic response in healthy subjects, as well as in overall efficacy and safe...
Autor:
Laura Arletti, Fabio Forghieri, Ivana Lagreca, Francesco Soci, Daniela Vallerini, Elisabetta Colaci, Cristina Mecucci, Emanuela Ottaviani, Valeria Fantuzzi, Valeria Pioli, Ambra Paolini, Vincenzo Nasillo, Patrizia Barozzi, Roberto Marasca, Patrizia Zucchini, Monica Morselli, Giovanna Leonardi, Franco Narni, Chiara Quadrelli, Goretta Bonacorsi, Valeria Coluccio, Laura Faglioni, Giorgia Corradini, Mario Luppi, Leonardo Potenza, Giovanni Riva, Giovanni Martinelli, Monica Maccaferri, Andrea Messerotti, Francesca Giacobbi, Brunangelo Falini, Sara Bigliardi
Nucleophosmin 1 (NPM1) gene mutations, resulting in aberrant cytoplasmic delocalization of NPM1 (NPMc+), are detected in about 30% of all de novo acute myeloid leukemia (AML) cases, and in 50–60% o...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3e0b6d191d58ffe451f52371cfbe6ea
http://hdl.handle.net/11585/548698
http://hdl.handle.net/11585/548698